Head-to-head comparisons of medication uses, side effects, warnings, and more.
Ryzneuta (efbemalenograstim alfa) is an injectable medication used to lower the risk of infection in adults with certain cancers who are getting chemotherapy that can cause low white blood cells. It's a long-acting growth factor that helps the body make more neutrophils, a type of white blood cell important for fighting infections. A healthcare professional will give it as a shot under the skin once during each chemotherapy cycle. Side effects include nausea, low red blood cells, and low platelet count.
Neulasta (pegfilgrastim) is an injectable medication that can lower your risk of infection when you have low white blood cells. It's usually used for people who've taken bone marrow-suppressing anticancer medications or have had exposure to radiation. It's similar to Neupogen (filgrastim), but lasts longer. There are many biosimilars to Neulasta (pegfilgrastim) available on the market, but they can't be switched without a new prescription.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.